Alto Neuroscience, Inc.
Biotechnology
Healthcare
ANRO
26.96 M shares
NYSE US
traded
09 Apr 2025
listed
no
open
2.00
52 week high
16.29
high
2.23
52 week low
1.80
previous Close
2.03
P/E ratio
market cap
105 M
div yield
0
net incoming
-16.78 M
-4.70 %
net profit margin
-1678300000.00 %
0.00 %
operating incoming
-18.89 M
-2.97 %
net change in cash
-11.42 M
6.94 %
cash on hand
182 M
-5.91 %
top